Skip to main content

BRIEF RESEARCH REPORT article

Front. Cell. Infect. Microbiol., 11 April 2024
Sec. Antibiotic Resistance and New Antimicrobial drugs
This article is part of the Research Topic Evolution, Molecular Mechanisms and the Strategies to Combat Antimicrobial Resistance (AMR): A One Health Approach View all 20 articles

AMR mechanisms in L. interrogans serovars: a comprehensive study

  • 1Department of Biochemistry and Pharmacology, Uzhhorod National University, Uzhhorod, Ukraine
  • 2Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

Antimicrobial resistance (AMR) is one of the global health challenges of the 21st century. Data regarding AMR mechanisms in Leptospira interrogans, the causative agents of leptospirosis, have been relatively limited. Therefore, our study aimed to identify resistance genes and explore potential resistance mechanisms specific to particular serovars. We conducted a comprehensive analysis of 98 Leptospira strains, representing 10 common serovars, using whole-genome sequencing (WGS) FASTA files. Employing the PATRIC tool from the Bacterial and Viral Bioinformatics Resource Center (BV-BRC), we scrutinized the genomes for AMR genes. Our investigation revealed 32 genes associated with AMR, with 20 key genes consistently prevalent across most strains. Notably, we identified unique efflux pump systems in serovar Pomona, indicating distinctive resistance mechanisms in this serovar. In summary, our findings shed light on the genetic landscape of AMR in Leptospira, uncovering both common and serovar-specific resistance elements. The presence of unique efflux pump systems in serovar Pomona introduces a novel dimension to our understanding of resistance mechanisms. These insights underscore the importance of tailored intervention strategies and collaborative efforts between human and veterinary healthcare professionals, as well as environmental scientists, to address the complex dynamics of leptospirosis and its implications for antibiotic resistance.

1 Introduction

Antimicrobial resistance (AMR) presents significant challenges in addressing bacterial infections across both animal and human populations (Arnold et al., 2016; Furness et al., 2017). The emergence and dissemination of antimicrobial-resistant microbes over the past few decades pose a severe global health threat (Pulingam et al., 2022). AMR not only increase morbidity and mortality but also substantially impacts treatment duration and costs (Murray et al., 2022).

Although leptospirosis is endemic in tropical geographic areas, it is known as one of the most considerable global zoonotic bacterial infections, which may lead to establishing epidemics on large scales as a result of flooding and strong rainfall (Haake and Levett, 2015; Rajapakse, 2022). The zoonotic infection of leptospirosis annually may cause one million cases with a mortality rate of 6.86% (approximately 60,000 deaths) around the world (Adler and de la Peña Moctezuma, 2010; Petakh and Nykyforuk, 2022; Petakh et al., 2023; Petakh et al., 2022a; Petakh et al., 2022b; Petakh et al., 2022c). The genus Leptospira comprises over 20 species based on DNA relatedness, with more than 350 serovars identified based on surface agglutinating lipopolysaccharide antigens (Adler and de la Peña Moctezuma, 2010; Fouts et al., 2016). These species are broadly categorized into three groups. Saprophytic species like Leptospira biflexa are not associated with disease. Pathogenic species such as Leptospira interrogans and Leptospira borgpetersenii cause leptospirosis globally, ranging from mild or asymptomatic infection to severe forms resulting in multiple organ failure and death. An intermediate group, including Leptospira fainei and Leptospira licerasiae, may be associated with infection and mild disease (Fouts et al., 2016).

Leptospira spp. exhibit intrinsic resistance to various antimicrobial agents, though the specific mechanisms responsible remain unidentified (Adler et al., 1986; Vinod Kumar et al., 2016; Petakh et al., 2024a; Petakh et al., 2024b). Nevertheless, resistance to sulfonamides, neomycin, actidione, polymyxin, nalidixic acid, vancomycin, and rifampicin has facilitated the development of selective media for isolating leptospires (Schönberg, 1981).

In recent research, genes linked to AMR have been explored using the Comprehensive Antibiotic Resistance Database (CARD) definition (McArthur et al., 2013; MaChado et al., 2022). The CARD definition outlines different modes of AMR action:

1. Antibiotic target in susceptible species: genes associated with antibiotic-sensitive wild-type bacterial components may undergo mutations, rendering them not susceptible.

2. Protein altering cell wall charge conferring antibiotic resistance: Genes involved in cell wall alteration, leading to changes in charge that confer resistance to antibiotics.

3. Gene conferring resistance via absence: deletion of specific genes or gene products results in resistance. For instance, deletion of a porin gene can block the entry of drugs into the cell.

4. Antibiotic inactivation enzyme: genes encoding enzymes that catalyze the inactivation of antibiotics, resulting in resistance: inactivation includes chemical modification, destruction, etc.

5. Efflux pump conferring antibiotic resistance: subunits of efflux proteins that pump antibiotics out of a cell to confer resistance.

6. Antibiotic target protection protein: these proteins confer antibiotic resistance by binding the antibiotic target to prevent antibiotic binding.

7. Antibiotic target modifying enzyme: enzymes that confer resistance by modifying (mutational alteration or enzymatic modification) antibiotic targets.

8. Regulator modulating expression of antibiotic resistance genes: mechanism activated by the presence of a specific antibiotic.

Current recommendations for treating human leptospirosis involve penicillin, ampicillin, ceftriaxone, or cefotaxime (Adler and de la Peña Moctezuma, 2010; Haake and Levett, 2015). Alternatives, particularly for those with allergies or in non-hospital settings, include oral doxycycline or azithromycin. In veterinary settings, a penicillin-streptomycin combination is the preferred therapy for acute leptospirosis, although ampicillin, amoxicillin, tetracyclines, tulathromycin, and third-generation cephalosporins have also been utilized (Ellis, 2015). Tilmicosin presents an additional alternative (Alt et al., 2001).

The apparent absence of significant antimicrobial resistance emergence in Leptospira prompts the question of why this has not occurred (Liegeon et al., 2018). Leptospiral infections are typically monomicrobial, limiting opportunities for horizontal resistance gene acquisition. Moreover, there is no experimental evidence of foreign DNA uptake by Leptospira spp., although genomic analyses support this notion. Finally, human leptospirosis is a dead-end infection, with human-to-human transmission being extremely rare (Trott et al., 2018).

The study of antimicrobial resistance (AMR) mechanisms in Leptospira interrogans serovars is crucial due to the increasing global burden of leptospirosis, a zoonotic disease caused by this bacterium (Boss et al., 2019). Understanding the mechanisms that contribute to AMR in different serovars is essential for developing effective treatment strategies and controlling the spread of resistant strains. In this comprehensive study, we aim to investigate the genetic and phenotypic characteristics of AMR in L. interrogans serovars, shedding light on the factors that drive resistance and providing valuable insights for future therapeutic interventions.

2 Materials and methods

We conducted an analysis of FASTA files obtained from the whole-genome sequencing (WGS) of 98 strains, representing 10 common serovars in humans and animals (Oliveira et al., 2017). The distribution of strains among the serovars is as follows: Australis (n = 1); Autumnalis (n = 1); Bataviae (n = 6); Canicola (n = 11); Copenhageni (n = 30); Grippotyphosa (n = 6); Icterohaemorrhagiae (n = 11); Manilae (n = 5); Pomona (n = 16); Pyrogenes (n = 11) (Supplementary Materials). Strains were collected during 1958 – 2020 years.

We employed the PATRIC tool from the Bacterial and Viral Bioinformatics Resource Center (BV-BRC) to analyze the genomes for antimicrobial resistance (AMR) genes. The Genome Annotation Service in PATRIC uses the k-mer-based AMR gene detection method, which utilizes PATRIC’s curated collection of representative AMR gene sequence variants and assigns to each AMR gene a functional annotation and a broad mechanism of antibiotic resistance (Wattam et al., 2017).

3 Results

The majority of strains were isolated in Brazil (n = 17) and the United Kingdom (n = 16) (Figure 1). Most of the strains were obtained from humans (n = 59). In general, five main mechanisms of resistance to antibiotics were identified: gene conferring resistance via absence; protein altering cell wall charge conferring antibiotic resistance; antibiotic activation enzyme; regulator modulating expression of antibiotic resistance genes; efflux pump conferring antibiotic resistance (Figure 2).

Figure 1
www.frontiersin.org

Figure 1 Serovar, isolation country, host distribution, and G/C content of investigated genomes.

Figure 2
www.frontiersin.org

Figure 2 Distribution of AMR genes across all strains.

The three predominant and widespread mechanisms were antibiotic target in susceptible species, gene conferring resistance via absence, and protein altering cell wall charge conferring antibiotic resistance, all of which were detected in all studied strains.

Seven genes (alr, ddl, dxr, EF-G, EF-Tu, folA, dfr) were observed in all studied strains. These genes are part of the antibiotic target in susceptible species. Antibiotic-sensitive wild-type bacterial components might undergo mutations that render them non-susceptible. All serovars had the folP gene, which encodes dihydropteroate synthase, the target enzyme of sulfonamides, except for one strain of serovar Pyrogenes (Leptospira interrogans serovar Pyrogenes str. R168). Additionally, Leptospira interrogans serovar Pyrogenes str. 200701872 did not have the gyrB gene, which encodes the B subunit of the DNA gyrase. Leptospira interrogans serovar Copenhageni str. M20 and Leptospira interrogans serovar Pyrogenes str. R168 did not have the MurA gene, a key enzyme involved in bacterial cell wall peptidoglycan synthesis and a target for the antimicrobial agent fosfomycin. Leptospira interrogans serovar Canicola strain Tande did not have the rpoB gene encoding the beta subunit of RNA polymerase (rpoB), the rpoC gene encoding DNA-directed RNA polymerase subunit beta, and the S12p gene encoding the small ribosomal protein.

Two mechanisms, antibiotic activation enzyme and regulator modulating expression of antibiotic resistance genes, were found among two strains of serovar Manilae. Specifically, the catalase-peroxidase enzyme KatG, encoded by the katG gene, and oxyR, the canonical orchestrator of the H2O2 detoxification response, were identified. Additionally, four strains of serovar Pomona exhibited efflux pump conferring antibiotic resistance (Figure 3). Specifically, in Leptospira interrogans serovar Pomona strain EMY7780, OprM/OprM family and TolC/OpmH were identified. In Leptospira interrogans serovar Pomona strain ESR8, AcrAB-TolC, AcrAD-TolC, and TolC/OpmH were observed. Strain P5661 of Leptospira interrogans serovar Pomona showed AcrAD-TolC, AcrEF-TolC, EmrAB-TolC, EmrD, MdtABC-TolC, and MexPQ-OpmE. Lastly, in Leptospira interrogans serovar Pomona strain Pom_str68, EmrAB-OMF was found.

Figure 3
www.frontiersin.org

Figure 3 Distribution of AMR genes across all serovars.

4 Discussion

In our study of 98 types of Leptospira bacteria, we discovered 32 genes linked to antimicrobial resistance (AMR). Out of these, 20 key genes consistently stood out in most strains. The highest number of genes was associated with a mechanism that makes antibiotics less effective in susceptible species, involving 17 different genes (Figure 4).

Figure 4
www.frontiersin.org

Figure 4 Mechanisms of AMR in L. interrogans strains.

Some crucial genes, such as alr and ddl, encode D-alanine racemase (Alr) and D-alanine:D-alanine ligase (Ddl), which are peptidoglycan biosynthetic enzymes. Feng reported that the overproduction of Alr in Mycobacterium smegmatis determines a d-Cycloserine resistance phenotype (Feng and Barletta, 2003).

Another important gene is murA, which is a key enzyme involved in bacterial cell wall peptidoglycan synthesis and is a target for the antimicrobial agent fosfomycin, a structural analog of the MurA substrate phosphoenol pyruvate (Kumar et al., 2009).

The dxr gene plays a significant role in building the cell membranes of bacteria. Fosmidomycin is a phosphonic antibiotic that inhibits 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr), the first committed step of the non-mevalonate pathway of isoprenoid biosynthesis. In Mycobacterium tuberculosis, Dxr is encoded by Rv2870c, and although the antibiotic has been shown to inhibit the recombinant enzyme, mycobacteria are intrinsically resistant to fosmidomycin at the whole-cell level (Brown and Parish, 2008).

For DNA replication and repair, DNA gyrase subunits (gyrA and gyrB) are like the repair crew for the bacterial DNA (Chien et al., 2016). Efflux pumps and mutations in gyrA, associated with fluoroquinolone resistance, have been induced in vitro in Brucella spp. strains. Think of these as defense mechanisms that bacteria develop to resist certain antibiotics.

An interesting discovery was made regarding certain strains of serovar Pomona. These strains possess different efflux pump systems that expel drugs, impacting bacterial resistance. This emphasizes the need to understand these variations for effective treatment. In study L. interrogans serovar Pomona isolates from swine in Brazil were found to be resistant to fluoroquinolones (Miraglia et al., 2008). We think that overexpression of efflux pumps might be the reason.

In a separate study by Antara Chakraborty and colleagues, 46 Leptospira isolates from rats were tested for their susceptibility to 14 antimicrobial agents (Chakraborty et al., 2010). All of the strains were found to be sensitive to ampicillin, cefotaxime, ciprofloxacin, norfloxacin, doxycycline, erythromycin, and streptomycin. In contrast, the tested isolates showed resistance to amphotericin B, 5-fluorouracil, fosfomycin, trimethoprim, sulfamethoxazole, neomycin, and vancomycin.

5 Conclusions

In the end, our research on AMR mechanisms in Leptospira interrogans serovars found 32 genes linked to resistance, with 20 key genes present in all strains. We believe these genes form the basis that ensures leptospira’s resistance to certain types of antibiotics. The diverse resistance profiles observed among different Leptospira interrogans serovars underscore the complexity of antimicrobial resistance mechanisms in this bacterium.

The identified serovar-specific resistance mechanisms raise the prospect of tailoring therapeutic approaches based on the prevalent serovar in a specific geographical area. A nuanced understanding of the resistance patterns associated with each serovar could lead to more effective and targeted treatment strategies.

Efflux pump systems identified in serovar Pomona, introduce a dimension of complexity to the management of leptospirosis. The potential contribution of these systems to AMR highlights the need for future research.

Given its status as a zoonotic disease, understanding the interplay between human, animal, and environmental factors is crucial for comprehensive intervention strategies. The identified resistance mechanisms should prompt collaborative efforts between human and veterinary healthcare professionals, as well as environmental scientists, to address the multifaceted nature of leptospirosis and its potential impact on antibiotic resistance dynamics.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Author contributions

PP: Conceptualization, Investigation, Visualization, Writing – original draft. OK: Conceptualization, Supervision, Visualization, Writing – original draft, Writing – review & editing.

Funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2024.1384427/full#supplementary-material

References

Adler, B., de la Peña Moctezuma, A. (2010). Leptospira and leptospirosis. Vet. Microbiol. 140, 287–296. doi: 10.1016/j.vetmic.2009.03.012

PubMed Abstract | CrossRef Full Text | Google Scholar

Adler, B., Faine, S., Christopher, W. L., Chappel, R. J. (1986). Development of an improved selective medium for isolation of leptospires from clinical material. Vet. Microbiol. 12, 377–381. doi: 10.1016/0378-1135(86)90087-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Alt, D. P., Zuerner, R. L., Bolin, C. A. (2001). Evaluation of antibiotics for treatment of cattle infected with Leptospira borgpetersenii serovar hardjo. J. Am. Vet. Med. Assoc. 219, 636–639. doi: 10.2460/javma.2001.219.636

PubMed Abstract | CrossRef Full Text | Google Scholar

Arnold, K. E., Williams, N. J., Bennett, M. (2016). 'Disperse abroad in the land': the role of wildlife in the dissemination of antimicrobial resistance. Biol. letters. 12, 20160137–20160145. doi: 10.1098/rsbl.2016.0137

CrossRef Full Text | Google Scholar

Boss, J., Dance, D. A. B., Chanthongthip, A., Newton, P. N., Wuthiekanun, V., Robinson, M. T. (2019). Antimicrobial susceptibility testing of leptospira spp. in the lao people's democratic republic using disk diffusion. Am. J. Trop. Med. Hyg. 100, 1073–1078. doi: 10.4269/ajtmh.18-0955

PubMed Abstract | CrossRef Full Text | Google Scholar

Brown, A. C., Parish, T. (2008). Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake. BMC Microbiol. 8, 78. doi: 10.1186/1471-2180-8-78

PubMed Abstract | CrossRef Full Text | Google Scholar

Chakraborty, A., Miyahara, S., Villanueva, S. Y., Gloriani, N. G., Yoshida, S. (2010). In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents. Antimicrobial. Agents chemother. 54, 5403–5405. doi: 10.1128/AAC.00973-10

CrossRef Full Text | Google Scholar

Chien, J. Y., Chiu, W. Y., Chien, S. T., Chiang, C. J., Yu, C. J., Hsueh, P. R. (2016). Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates. Antimicrobial. Agents chemother. 60, 2090–2096. doi: 10.1128/AAC.01049-15

CrossRef Full Text | Google Scholar

Ellis, W. A. (2015). Animal leptospirosis. Curr. topics Microbiol. Immunol. 387, 99–137. doi: 10.1007/978-3-662-45059-8_6

CrossRef Full Text | Google Scholar

Feng, Z., Barletta, R. G. (2003). Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine. Antimicrobial. Agents chemother. 47, 283–291. doi: 10.1128/AAC.47.1.283-291.2003

CrossRef Full Text | Google Scholar

Fouts, D. E., Matthias, M. A., Adhikarla, H., Adler, B., Amorim-Santos, L., Berg, D. E., et al. (2016). What makes a bacterial species pathogenic?:Comparative genomic analysis of the genus leptospira. PloS Negl. Trop. Dis. 10, e0004403. doi: 10.1371/journal.pntd.0004403

PubMed Abstract | CrossRef Full Text | Google Scholar

Furness, L. E., Campbell, A., Zhang, L., Gaze, W. H., McDonald, R. A. (2017). Wild small mammals as sentinels for the environmental transmission of antimicrobial resistance. Environ. Res. 154, 28–34. doi: 10.1016/j.envres.2016.12.014

PubMed Abstract | CrossRef Full Text | Google Scholar

Haake, D. A., Levett, P. N. (2015). Leptospirosis in humans. Leptospira leptospirosis. 387, 65–97. doi: 10.1007/978-3-662-45059-8_5

CrossRef Full Text | Google Scholar

Kumar, S., Parvathi, A., Hernandez, R. L., Cadle, K. M., Varela, M. F. (2009). Identification of a novel UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Vibrio fischeri that confers high fosfomycin resistance in Escherichia coli. Arch. Microbiol. 191, 425–429. doi: 10.1007/s00203-009-0468-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Liegeon, G., Delory, T., Picardeau, M. (2018). Antibiotic susceptibilities of livestock isolates of leptospira. Int. J. antimicrobial. agents. 51, 693–699. doi: 10.1016/j.ijantimicag.2017.12.024

CrossRef Full Text | Google Scholar

MaChado, D., Barbosa, J. C., Almeida, D., Andrade, J. C., Freitas, A. C., Gomes, A. M. (2022). Insights into the Antimicrobial Resistance Profile of a Next Generation Probiotic Akkermansia muciniphila DSM 22959. Int. J. Environ. Res. Public Health 19, 9152–9167. doi: 10.3390/ijerph19159152

PubMed Abstract | CrossRef Full Text | Google Scholar

McArthur, A. G., Waglechner, N., Nizam, F., Yan, A., Azad, M. A., Baylay, A. J., et al. (2013). The comprehensive antibiotic resistance database. Antimicrobial. Agents chemother. 57, 3348–3357. doi: 10.1128/AAC.00419-13

CrossRef Full Text | Google Scholar

Miraglia, F., Moreno, A. M., Gomes, C. R., Paixão, R., Liuson, E., Morais, Z. M., et al. (2008). Isolation and characterization of Leptospira interrogans from pigs slaughtered in São Paulo State, Brazil. Braz. J. Microbiol. 39, 501–507. doi: 10.1590/S1517-83822008000300017

PubMed Abstract | CrossRef Full Text | Google Scholar

Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet (London England). 399, 629–655. doi: 10.1016/S0140-6736(21)02724-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Oliveira, M. A. A., Leal, É., Correia, M. A., Serufo Filho, J. C., Dias, R. S., Serufo, J. C. (2017). Human leptospirosis: occurrence of serovars of Leptospira spp. in the state of Minas Gerais, Brazil, from 2008 to 2012. Braz. J. Microbiol. 48, 483–488. doi: 10.1016/j.bjm.2016.12.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Petakh, P., Isevych, V., Griga, V., Kamyshnyi, A. (2022a). The risk factors of severe leptospirosis in the Transcarpathian region of Ukraine–search for “red flags”. Arch. Balk Med. Union. 57, 231–237. doi: 10.31688/ABMU

CrossRef Full Text | Google Scholar

Petakh, P., Isevych, V., Kamyshnyi, A., Oksenych, V. (2022b). Weil's disease-immunopathogenesis, multiple organ failure, and potential role of gut microbiota. Biomolecules 12, 1830–1847. doi: 10.3390/biom12121830

PubMed Abstract | CrossRef Full Text | Google Scholar

Petakh, P., Isevych, V., Mohammed, I. B., Nykyforuk, A., Rostoka, L. (2022c). Leptospirosis: prognostic model for patient mortality in the transcarpathian region, Ukraine. Vector borne zoon. Dis. (Larchmont NY). 22, 584–588. doi: 10.1089/vbz.2022.0063

CrossRef Full Text | Google Scholar

Petakh, P., Nykyforuk, A. (2022). Predictors of lethality in severe leptospirosis in Transcarpathian region of Ukraine. Le infezioni medicina. 30, 272–276. doi: 10.53854/liim-3002-13

CrossRef Full Text | Google Scholar

Petakh, P., Oksenych, V., Kamyshna, I., Boisak, I., Lyubomirskaya, K., Kamyshnyi, O. (2024a). Exploring the complex interplay: gut microbiome, stress, and leptospirosis. Front. Microbiol. 15, 1345684–1345700. doi: 10.3389/fmicb.2024.1345684

PubMed Abstract | CrossRef Full Text | Google Scholar

Petakh, P., Oksenych, V., Kamyshnyi, O. (2024b). Exploring Leptospira interrogans FDAARGOS_203: Insights into AMR and Anti-Phage Defense. Microorganisms 12, 3, 546. doi: 10.3390/microorganisms12030546

PubMed Abstract | CrossRef Full Text | Google Scholar

Petakh, P., Rostoka, L., Isevych, V., Kamyshnyi, A. (2023). Identifying risk factors and disease severity in leptospirosis: A meta-analysis of clinical predictors. Trop. doctor. 53, 464–469. doi: 10.1177/00494755231187673

CrossRef Full Text | Google Scholar

Pulingam, T., Parumasivam, T., Gazzali, A. M., Sulaiman, A. M., Chee, J. Y., Lakshmanan, M., et al. (2022). Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur. J. Pharm. Sci. 170, 106103. doi: 10.1016/j.ejps.2021.106103

PubMed Abstract | CrossRef Full Text | Google Scholar

Rajapakse, S. (2022). Leptospirosis: clinical aspects. Clin. Med. 22, 14. doi: 10.7861/clinmed.2021-0784

CrossRef Full Text | Google Scholar

Schönberg, A. (1981). Studies on the effect of antibiotic substances on leptospires and their cultivation from material with a high bacterial count. Zentralblatt fur Bakteriologie 1 Abt Originale A: Medizinische Mikrobiologie Infektionskrankheiten und Parasitologie. 249, 400–406. doi: 10.1016/S0174-3031(81)80096-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Trott, D. J., Abraham, S., Adler, B. (2018). Antimicrobial resistance in leptospira, brucella, and other rarely investigated veterinary and zoonotic pathogens. Microbiol. spect. 6. doi: 10.1128/microbiolspec.ARBA-0029-2017

CrossRef Full Text | Google Scholar

Vinod Kumar, K., Lall, C., Raj, R. V., Vedhagiri, K., Sunish, I. P., Vijayachari, P. (2016). In vitro antimicrobial susceptibility of pathogenic leptospira biofilm. Microbial. Drug resist. (Larchmont NY). 22, 511–514. doi: 10.1089/mdr.2015.0284

CrossRef Full Text | Google Scholar

Wattam, A. R., Davis, J. J., Assaf, R., Boisvert, S., Brettin, T., Bun, C., et al. (2017). Improvements to PATRIC, the all-bacterial bioinformatics database and analysis resource center. Nucleic Acids Res. 45, D535–Dd42. doi: 10.1093/nar/gkw1017

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: Leptospira interrogans, antibiotic, resistance, leptospiral serovars, leptospirosis

Citation: Petakh P and Kamyshnyi O (2024) AMR mechanisms in L. interrogans serovars: a comprehensive study. Front. Cell. Infect. Microbiol. 14:1384427. doi: 10.3389/fcimb.2024.1384427

Received: 09 February 2024; Accepted: 26 March 2024;
Published: 11 April 2024.

Edited by:

Nayeem Ahmad, Arabian Gulf University, Bahrain

Reviewed by:

M. Oves, King Abdulaziz University, Saudi Arabia
Pankaj Dhaka, Guru Angad Dev Veterinary and Animal Sciences University, India
Dalia Hamza, Cairo University, Egypt

Copyright © 2024 Petakh and Kamyshnyi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Pavlo Petakh, cGF2bG8ucGV0YWtoQHV6aG51LmVkdS51YQ==; Oleksandr Kamyshnyi, a2FteXNobnlpX29tQHRkbXUuZWR1LnVh

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.